These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 888497)

  • 21. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. The role of serum human placental lactogen determination.
    Vorster CZ; Pannall PR; Slabber CF
    S Afr Med J; 1977 Feb; 51(6):165-6. PubMed ID: 841444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of radioimmunological HPL findings in the long-term care of threatened abortion].
    Ruckhäberle KE; Bilek K; Viehweg B; Kühndel K; Colditz U; Bär G
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():43-9. PubMed ID: 6242693
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of habitual abortion with caprovestrol].
    Kovtumova LG; Turbina ZV; Rymashevskaia EP; Zelenkova LT
    Vopr Okhr Materin Det; 1976 May; 21(5):72-5. PubMed ID: 1027289
    [No Abstract]   [Full Text] [Related]  

  • 25. [Correlation of maternal serum concentration of HPL and SP-1 in the second half of pregnancy (author's transl)].
    Tatra G; Scheiber V
    Z Geburtshilfe Perinatol; 1978 Jun; 182(3):234-7. PubMed ID: 685355
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal supervision of threatened abortion. diagnosis and therapy (author's transl)].
    Knapstein P
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):970-2. PubMed ID: 6775195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum HPL level in maternal vein, umbilical cord artery and vein in term and preterm birth.
    Hercz P; Mohari K; Kocsár L; Siklós P; Ungár L
    Acta Physiol Hung; 1986; 67(2):243-6. PubMed ID: 3739748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between the estimation of placental lactogen with other methods in risk pregnancies (author's transl)].
    Sorfová J; Misinger I; Papez L; Dolezalová B; Filipovicová M; Sindlár M
    Cesk Gynekol; 1976 Nov; 41(9):646-9. PubMed ID: 1000655
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of long-term beta adrenergic therapy on the HPL blood level and the total excretion of estrogens].
    Wilken HP; Lauckner W; Dässler CG; Kunkel S
    Zentralbl Gynakol; 1977; 99(22):1366-70. PubMed ID: 602505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary oestriol and serum activities of human placental lactogen and heat stable alkaline phosphatase as indicators of fetoplacental function.
    Karjalainen O; Stenman U; Widholm O
    Ann Chir Gynaecol Fenn; 1975; 64(1):50-4. PubMed ID: 1155905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The treatment of threatened abortion (author's transl)].
    Berle P; Behnke K
    Geburtshilfe Frauenheilkd; 1977 Feb; 37(2):139-42. PubMed ID: 320090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum HPL in early pregnancy: diagnostic and prognostic value (author's transl)].
    Janisch H; Spona J
    Z Geburtshilfe Perinatol; 1973 Oct; 177(5):349-55. PubMed ID: 4777492
    [No Abstract]   [Full Text] [Related]  

  • 34. [The treatment of imminent abortion with monitoring of the maternal serum HPL level (proceedings)].
    Berle P; Behnke K
    Arch Gynakol; 1977 Jul; 224(1-4):90-1. PubMed ID: 341834
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1975 Jan; 121(2):257-61. PubMed ID: 46714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Threatened abortion and its treatment].
    Soiva K
    Duodecim; 1974; 90(4):267-75. PubMed ID: 4603922
    [No Abstract]   [Full Text] [Related]  

  • 37. [Radioimmunologic determination of placental lactogenic hormone in threatened spontaneous abortion. Prognostic value compared with determination of chorionic gonadotrophic hormone (HCG)].
    Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(1):53-62. PubMed ID: 4807227
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prognosis and treatment of threatened abortion. A. Prognostic value of maternal serum determination of choriogonadotropin and its free alpha and beta subunits in threatened abortion of the first trimester: correlation with ultrasonographic examination].
    Gaspard U; Schaaps JP; Piront F; Deville JL; Reuter AM; Vrindts-Gevaert Y; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):62-6. PubMed ID: 7451883
    [No Abstract]   [Full Text] [Related]  

  • 39. Human placental lactogen is a first-trimester maternal serum marker of Down syndrome.
    Christiansen M; Sørensen TL; Nørgaard-Pedersen B
    Prenat Diagn; 2007 Jan; 27(1):1-5. PubMed ID: 17154235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is hormonal therapy still justified in imminent abortion? (author's transl)].
    Berle P; Budenz M; Michaelis J
    Z Geburtshilfe Perinatol; 1980 Oct; 184(5):353-8. PubMed ID: 7197091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.